Cargando…
A dendritic cell-targeted chimeric hepatitis B virus immunotherapeutic vaccine induces both cellular and humoral immune responses in vivo
Chimigen® HBV Immunotherapeutic Vaccine (C-HBV), a recombinant chimeric fusion protein comprising hepatitis B virus (HBV) S1 and S2 surface antigen fragments, Core antigen and a murine monoclonal antibody heavy chain fragment (Fc), was designed and produced in Sf9 insect cells. C-HBV targets the hos...
Autores principales: | George, Rajan, Ma, Allan, Motyka, Bruce, Shi, Yuenian Eric, Liu, Qiang, Griebel, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227651/ https://www.ncbi.nlm.nih.gov/pubmed/31687875 http://dx.doi.org/10.1080/21645515.2019.1689081 |
Ejemplares similares
-
A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B
por: Ma, Allan, et al.
Publicado: (2019) -
Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
por: Hasan, Amal, et al.
Publicado: (2021) -
Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes
por: Khan, Farhan Ullah, et al.
Publicado: (2022) -
A Trifunctional Dextran-Based Nanovaccine Targets and Activates Murine Dendritic Cells, and Induces Potent Cellular and Humoral Immune Responses In Vivo
por: Shen, Limei, et al.
Publicado: (2013) -
Plasma Cytokines and Birth Weight as Biomarkers of Vaccine-Induced Humoral Responses in Piglets
por: Lipsit, Sean, et al.
Publicado: (2022)